Quinstreet, Inc: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 8, 2026 and accepted by EDGAR at May 8, 2026, 12:22 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $346.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2025-07-01 to 2026-03-31 | $919.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $304.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2025-07-01 to 2026-03-31 | $823.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2026-01-01 to 2026-03-31 | $41.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2025-07-01 to 2026-03-31 | $96.0m | us-gaap:GrossProfit |
| Research and development | 3 months2026-01-01 to 2026-03-31 | $10.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-07-01 to 2026-03-31 | $26.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2026-01-01 to 2026-03-31 | $10.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-07-01 to 2026-03-31 | $16.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-01-01 to 2026-03-31 | $2.1m | us-gaap:InterestExpense |
| Interest expense | 9 months2025-07-01 to 2026-03-31 | $2.2m | us-gaap:InterestExpense |
| Income tax | 3 months2026-01-01 to 2026-03-31 | $822.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-07-01 to 2026-03-31 | −$47.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | $7.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-07-01 to 2026-03-31 | $62.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-07-01 to 2026-03-31 | $1.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | $0.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-07-01 to 2026-03-31 | $1.09 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 58,038,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-07-01 to 2026-03-31 | 58,242,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-07-01 to 2026-03-31 | $78.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-07-01 to 2026-03-31 | $2.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2025-07-01 to 2026-03-31 | $16.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-03-31 | $102.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-03-31 | $295.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $704.3m | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $249.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $394.0m | us-gaap:Liabilities |
| Long-term debt | At period end2026-03-31 | $70.0m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2026-03-31 | $310.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-26-213979. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.